# Papua New Guinean Duffy Negativity And Vivax Malar

> **NCT00138489** · — · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 266 (—)

## Conditions studied

- Plasmodium Vivax Malaria

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00138489
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2004-02-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 266 (—)
- **Last updated:** 2019-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00138489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00138489, "Papua New Guinean Duffy Negativity And Vivax Malar". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00138489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*